S. Yamada

发表

New Imaging Findings in a Patient with Central Nervous System Dysfunction after Bone Marrow Transplantation

M. Okada, Y. Fujimori, H. Nishimura, 2000, Acta Haematologica.

Good response to cyclosporine therapy in patients with myelodysplastic syndrromes having the HLA-DRB1*1501 allele

M. Okada, Y. Takemoto, H. Takatsuka, 2000, Leukemia.

Herpesvirus Infection in Patients Following Bone Marrow Transplantation: Influence of Viral Reactivation on Prognosis

M. Okada, Y. Fujimori, A. Kanamaru, 2001, Hematology.

Cytokines and Cytomegalovirus Disease Following Allogeneic Bone Marrow Transplantation

A. Kanamaru, Y. Takemoto, H. Takatsuka, 2001, Hematology.

Long-Term Administration of Oral Low-Dose Topoisomerase II Inhibitors, MST-16 and VP-16, for Refractory or Relapsed Non-Hodgkin’s Lymphoma

M. Okada, Y. Fujimori, H. Takatsuka, 2001, Acta Haematologica.

Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome

Y. Fujimori, A. Kanamaru, Y. Takemoto, 2000, Bone Marrow Transplantation.

Similarity Between Eruptions Induced by Sulfhydryl Drugs and Acute Cutaneous Graft-versus-host Disease After Bone Marrow Transplantation

Y. Fujimori, A. Kanamaru, Y. Takemoto, 2002, Hematology.

Similarity Between Multiple Sclerosis and Idiopathic Central Nervous System Dysfunction After Bone Marrow Transplantation

Y. Fujimori, A. Kanamaru, Y. Takemoto, 2001, Hematology.

Successful Treatment of Chronic Graft-versus-Host Disease with Sulfasalazine in Allogeneic Bone Marrow Transplantation

M. Okada, Y. Fujimori, Y. Takemoto, 1999, Acta Haematologica.

Oral eicosapentaenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation.

M. Okada, A. Kanamaru, Y. Takemoto, 2002, Drugs under experimental and clinical research.

Cytokines and Cytomegalovirus Disease Following Allogeneic Bone Marrow Transplantation

A. Kanamaru, Y. Takemoto, H. Takatsuka, 2001, Hematology.